Whereas low-depend MBL almost never progresses to CLL, superior-depend MBL progresses to CLL necessitating therapy at a rate of 1% to two% each year. Significant-count MBL is distinguished from Rai 0 CLL dependant on whether the B-mobile depend is previously mentioned or down below 5 × 109/L. While people today with both high-count MBL and CLL Rai